Abstract Library

#1692 A Case Report of NET G1 of the Gallbladder

Introduction: The SEER database has shown that gallbladder NET is 0.5% of all NET cases, and G1 cases are limited to 2% in the rare gallbladder NET cases.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Nakano K, Masui T, Uchida Y, Sato A, Sasaki N,

Keywords: NET G1, gallbladder,

#1690 18F-FDG-PET to Discriminate Biologically Malignant Pancreatic Neuroendocrine Tumors

Introduction: 18F-FDG-PET is widely used to detect malignant tumors. However, the efficacy for pancreatic neuroendocrine tumors (PNETs) is reported to be limited in the clinical practice.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Sato A, Toshihiko M, Kenzo N, Yuichiro U, Yuji N,

Keywords: 18F-FDG-PET, pancreatic neuroendocrine tumors (p-nets), metastasis,

#1670 A Successful Case of Controlling the Multiple Distant Metastasis of Pancreatic G2 NET with Local Therapy Combined with Systemic Pharmacotherapy

Introduction: Several systemic pharmacotherapies could be applied to multiple metastatic pancreatic neuroendocrine tumor (PNET). However, we have not determined how to coordinate ‘local’ therapy such as salvage surgery and transarterial chemoembolization with systemic pharmacotherapies for these multiple metastatic PNET.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Uchida Y, Masui T, Kenzo N, Asahi S, Shinji U,

Keywords: PNET, salvage surgery, TACE,

#1168 Simultaneous Large Cell Neuroendocrine Carcinoma and Adenocarcinoma of the Stomach: A Case Report and Literature Review

Introduction: Large cell neuroendocrine carcinoma (LCNEC) of the stomach is rare. Gastric NEC occasionally has another component, such as adenocarcinoma, in the same tumor. However, the concurrent occurrence of LCNEC and adenocarcinoma at different sites in the stomach is extremely rare.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Nakazuru S, Matsumura Y, Harada Y, Iwasaki R, Iwasaki T,

Keywords: stomach, large cell neuroendocrine carcinoma, tubular adenocarcinoma, simultaneous,

#597 Primary Hepatic Neuroendocrine Carcinomas Treated with a Combination of Cisplatin and Etoposide as First-Line Chemotherapy: Two Case Reports

Introduction: Because primary hepatic neuroendocrine carcinoma (PHNEC) is extremely rare, a standard regimen has not yet been established. However, the combination of etoposide and cisplatin (EP) has been widely used to treat PHNEC.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Nakazuru S, Iwasaki R, Tamura T, Iwasaki T, Hasegawa H,

Keywords: liver, neuroendocrine carcinoma, chemotherapy,